It is expected to roll out preventive and proactive strategies, train and qualify specialists, and prepare scientific research and forecasting studies
The National Health Regulatory Authority (NHRA) today approved the emergency use of the oral Covid-19 antiviral, Paxlovid. The medication has been authorised for individuals 18 years old and above who suffer from mild to moderate symptoms and are at an increased risk of developing severe Covid-19 that may lead to mortality.
The decision follows the evaluation of data provided by the manufacturer Pfizer, carried out by the NHRA's Pharmaceutical Products Regulation Department (PPR).
The NHRA noted that The Ministry of Health has begun importing procedures in accordance with the relevant standards and requirements, with the medication expected to arrive in January.
ALSO READ:
Paxlovid consists of two, co-packaged antiviral medicine (PF-07321332 and Ritonavir) that are designed to stop the virus causing Covid-19 from multiplying in the body and therefore help those infected to overcome the viral infection.
It is expected to roll out preventive and proactive strategies, train and qualify specialists, and prepare scientific research and forecasting studies
A wave of exceptionally hot weather has blasted parts of South and Southeast Asia this week
These ports will be used for take-off and landing of flying vehicles and serve as hubs for passenger pick-up, drop-off, and battery charging
The luxurious PORSCHE DESIGN HONOR Magic V2 RSR and PORSCHE DESIGN HONOR Magic6 RSR editions are available only through invitation, adding more exclusivity and uniqueness
Many motorists who have their vehicles written off will also look for a new one, driving the demand
Spot gold was steady at $2,317.41 per ounce after staying mostly in negative territory earlier in the day
It is likely to be humid by night and Friday morning over some coastal and internal areas
The Abu Dhabi Awards winner encourages everyone, regardless of their land size, to engage in farming